News

Applications are invited for a fully-funded 3-year PhD Industrial position to be carried out at Iproteos S.L, a small biotech- pharma company located at Barcelona Science Park (Spain) in collaboration with Institute for Research on Biomedicine of Barcelona (IRB Barcelona).

The project aims to discover and synthesize new peptidic drugs to modulate the biological activity of proteins involved in the progress and the chronic progress of epilepsy through the combination of both computational and experimental methods.

Iproteos is attending the 10th MIHealth Forum Healthcare that will be held on 27th of June 2013 at Barcelona. The program of MIHealth can be found here    

The Annual General Meeting of Shareholders 2013 will be held on Wednesday 19th of June.  

Iproteos has attended to the Bio-Europe Spring 2013 Meeting which has been held in Barcelona between 11th - 13th March.

Moreover, a special monographic section detailing the interview carried out by La Vanguardia newspapers can be found elsewhere (see attached PDF file), detailing some key aspects about Iproteos.

Interview to Teresa Tarrago published at La Vanguardia

Iproteos is attending the 8th Symposium of Proteinase Inhibitor Design that will be held at Novartis, Basel (Switzerland) on 15th and 16th of April. Further information can be found elsewhere: http://www.maggichurchouseevents.co.uk/BMCS/proteinase-2013.htm

Iproteos has been invited to conduct a talk at Therapheutic Peptide Network Conference that will be held on 1st March 2013. Further information can be found elsewhere: http://www.irbbarcelona.org/index.php/en/events/other-events/therapeutic-peptides?tab=presentation